Janssen Presents Initial Results for CMA CAR-TTherapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

  • Deepu Madduri

Press/Media

Period7 Dec 2019 → 9 Dec 2019

Media coverage

2

Media coverage